A pharmaceutical company is developing a new inhibitor for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to reduce lactate production in cancer cells. In vitro kinetic studies show that the inhibitor binds only to the enzyme-substrate complex and does NOT bind to the free enzyme. Which investigation would best confirm this uncompetitive inhibition mechanism?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.